Although the rule is designed to stabilize the marketplace and encourage issuer participation while an alternative health care law is being developed, health care legal experts aren’t so sure it will have that effect.
“While I think this proposed rule has some helpful elements and has features that issuers have asked for to varying degrees, it’s not going to change the overall uncertainty of where the marketplaces, where the exchanges are going,” says Christine Clements, a partner in Crowell & Moring’s health care group.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
